Target intelligence / Profile preview

ATP-dependent RNA helicase DHX33 (DHX33)

Target
DHX33
Molecular classification
Enzyme, RNA helicase, DEAD/DEAH box helicase family
01

Overview

ATP-dependent RNA helicase DHX33 is a member of the DEAH box family of RNA helicases characterized by the Asp-Glu-Ala-His (DEAH) motif[2][4]. DHX33 functions as an essential enzyme in multiple aspects of RNA metabolism, including unwinding secondary structures in RNA to promote translation initiation, facilitating ribosome biogenesis via nucleolar organization, and sensing cytosolic double-stranded RNA to activate immune responses such as NLRP3 inflammasome formation and type I interferon production[1][2][3][4]. DHX33 is required for global protein synthesis, cell growth, and proliferation, and is induced by oncogenic signaling pathways. It is involved in both normal cellular physiology and disease, notably as a critical driver in cancer and inflammation, and represents a promising therapeutic target due to its central role in mRNA translation and cell proliferation[1][3][4][5].

Other names
DEAH-box helicase 33DDX33FLJ21972DKFZp762F2011DEAH box protein 33DEAD/H box polypeptide 33DEAH box protein 33, putative
02

Mechanism of action

Inhibition of DHX33 helicase activity impairs ribosome biogenesis and disrupts mRNA translation, leading to reduced protein synthesis and cell proliferation[1][4][5]. Activation of ferroptosis pathway (for KY386)[5].

03

Biological functions

mRNA translation initiationRibosome biogenesisRNA metabolismSensing of cytosolic double-stranded RNA (dsRNA)Protein synthesisInduction of type I interferon productionInflammasome activationCell growth and proliferation
04

Disease associations

CancerInfectionInflammation
05

Safety considerations

Essential role in normal cell growth and viability could lead to toxicity if broadly inhibited[1][2]
06

Interacting drugs

KY386[5]
07

Biomarkers

Elevated DHX33 expression as a marker of certain cancers[5]DHX33 association to cell proliferation status[1][2]

Beyond the preview

Go deeper on ATP-dependent RNA helicase DHX33 (DHX33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-dependent RNA helicase DHX33 (DHX33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call